Article
Saturation mutagenesis identifies activating and resistance-inducing FGFR kinase domain mutations.
Nature genetics - 1 Jan 2026
Tangermann Carla, Ghosh Avantika, Ziegler Martin, Facchinetti Francesco, Stappenbeck Jannis, Carus Sahin Yagmur Oyku, Riester Marisa, Viardot Luise Carmina, Zundel Tobias, Friboulet Luc, Hollebecque Antoine, Naveja José J, Wanninger Angela, Hess Maria Elena, Brummer Tilman, Boerries Melanie, Loges Sonja, Loriot Yohann, Illert Anna L, Diederichs Sven
Abstract excerpt
Variants of uncertain significance represent the biggest challenge for genomics-based precision oncology. Activated fibroblast growth factor receptors (FGFRs) frequently drive tumorigenesis by different genetic aberrations. However, it remains unknown which of the many point mutations affecting FGFR1, FGFR2, FGFR3 or FGFR4 in cancer are druggable, that is, activating signaling while not mediating FGFR inhibitor...
Topics
Join the communities discussing this publication.
